REFRACTORY CHRONIC COUGH
Clinical trials for REFRACTORY CHRONIC COUGH explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY CHRONIC COUGH trials appear
Sign up with your email to follow new studies for REFRACTORY CHRONIC COUGH, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for chronic coughers: experimental drug enters final testing phase
Symptom relief Recruiting nowThis study tests an experimental drug called BLU-5937 in adults who have had a stubborn cough for at least a year that hasn't improved with other treatments. About 75 people in China will receive either the drug or a placebo for 24 weeks to see if it reduces coughing and is safe.…
Matched conditions: REFRACTORY CHRONIC COUGH
Phase: PHASE3 • Sponsor: GlaxoSmithKline • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Could antidepressants finally silence chronic cough?
Symptom relief Recruiting nowThis study tests whether two common antidepressants, duloxetine and amitriptyline, can reduce coughing in people with refractory chronic cough—a cough that persists despite standard treatments. About 50 adults will receive either a low or high dose of one drug or a placebo for 4 …
Matched conditions: REFRACTORY CHRONIC COUGH
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
Can a phone app tame a chronic cough?
Symptom relief Recruiting nowThis study tests whether a smartphone app called CoughPro can help adults with a long-lasting, unexplained cough. Twenty participants will use the app's cough management lessons for four weeks while wearing a smartwatch that counts their coughs. The goal is to see if the app redu…
Matched conditions: REFRACTORY CHRONIC COUGH
Phase: NA • Sponsor: Hyfe Inc • Aim: Symptom relief
Last updated Jun 26, 2026 15:35 UTC